FDA product code NJR: Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test
NJR is the FDA product code for nucleic acid amplification assay system, group b streptococcus, direct specimen test. It is a Class I device, regulated under 21 CFR 866.3740 and reviewed by the Microbiology panel. FDA has cleared 18 510(k) submissions under NJR, 2 in the last five years, from 12 different applicants. The average 510(k) review took 171 days (median 122). FDA has posted 11 recalls for NJR devices, 4 initiated in the last five years.
Definition
A nucleic acid amplification assay system (including probes, other reagents, and instrumentation) is an aid in the identification of group b streptococci from pre-partum and intra-partum women to establish colonization status.
Classification
| Field | Value |
|---|---|
| Device name | Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test |
| Device class | Class I |
| Regulation | 21 CFR 866.3740 |
| Review panel | MI — Microbiology |
| Medical specialty | Microbiology |
| Premarket route | 510(k) exempt |
510(k) clearances per year for NJR
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 2 | 81 |
| 2018 | 3 | 116 |
| 2022 | 1 | 535 |
| 2023 | 1 | 391 |
Compare with all 510(k) review times · Search every NJR clearance
Top NJR applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Cepheid | 5 | 2023-09-27 |
| Quidel Corporation | 2 | 2017-12-21 |
| Meridian Bioscience, Inc. | 2 | 2012-05-01 |
| Diasorin Molecular, LLC | 1 | 2018-11-07 |
| Diagenode | 1 | 2018-07-27 |
7 more applicants have NJR clearances. See the full list in Caduvo.
Most recent NJR clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K222638 | Cepheid | Xpert® Xpress GBS, GeneXpert® Dx System, GeneXpert® Infinity Systems | 2023-09-27 | 391 |
| K203429 | Cepheid | Xpert GBS LB XC, GeneXpert Dx System, GeneXpert Infinity System | 2022-05-09 | 535 |
| K182467 | Diasorin Molecular, LLC | Simplexa GBS Direct, Simplexa GBS Positive Control Pack | 2018-11-07 | 58 |
| K181156 | Diagenode | Panther Fusion GBS Assay | 2018-07-27 | 87 |
| K173725 | Neumodx Molecular, Inc. | NeuMoDx GBS Assay | 2018-06-26 | 203 |
Recalls for NJR devices
11 product recalls in 11 recall events; 4 initiated in the last five years and 5 still open. Most recent: 2025-10-07.
| Year | Recalls |
|---|---|
| 2019 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Frequently asked questions
What is FDA product code NJR?
NJR is the FDA product code for nucleic acid amplification assay system, group b streptococcus, direct specimen test. It is a Class I device, regulated under 21 CFR 866.3740 and reviewed by the Microbiology panel.
What device class is NJR?
Class I, regulation 21 CFR 866.3740. Typical premarket route: 510(k) exempt.
How long does a 510(k) take for product code NJR?
Across 18 cleared submissions the average was 171 days from receipt to decision (median 122).
Which companies have the most NJR clearances?
Cepheid (5); Quidel Corporation (2); Meridian Bioscience, Inc. (2); Diasorin Molecular, LLC (1); Diagenode (1).
Have NJR devices been recalled?
Yes: 11 product recalls across 11 recall events; the most recent began 2025-10-07.
Next steps
- Run an FDA pathway report with predicate devices for product code NJR
- Run a recall and safety report across every NJR manufacturer
- Watch product code NJR for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times